Zota Health Care LImited
Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products across boundaries into the semi-regulated and regulated markets of Asian Countries markets of African Countries, Russian Countries & Latin America.
What Zota files
- Others83
- Investor Meet32
- Updates30
- QIP/Rights/Pref.22
- Board Meeting16
- Important16
**Business Performance:** Zota Health Care kicked off Q1FY27 with strong revenue of ₹173.60 Cr, largely driven by its Davaindia generic pharmacy chain, which contributed ₹143.42 Cr. Davaindia shows robust growth with ~58% CAGR since FY22 and high customer loyalty, boasting 80% repeat customers. However, the company reported a Q1FY27 loss...
Zota Health Care FY26 Highlights: **Business Performance:** Zota delivered stellar performance, with consolidated revenue soaring 84% YoY to ₹538.66 Cr! 🚀 Davaindia segment was the growth engine, hitting ₹417.41 Cr. Importantly, the company turned profitable at the EBITDA level, reporting ₹25.98 Cr for FY26, a major turnaround from previous losses....
Zota Health Care LImited has informed the Exchange about Investor Presentation
Zota Health Care's Davaindia retail generic pharmacy is its primary growth engine, now boasting 2,055+ stores (1,207 COCO, 848 FOFO) as of H1FY26. For H1FY26, total revenue from operations was ₹232.53 Cr, with Davaindia contributing 73%. The company reported a gross profit of ₹134.95 Cr (58% margin) and an operating...
Zota Health Care reported strong Q2FY26 performance, with consolidated revenue soaring 92% year-over-year to ₹128.95 Cr. Gross Merchandise Value (GMV) more than doubled to ₹107.03 Cr, driven by a significant increase in quarterly footfalls. The Davaindia retail generic pharmacy chain remains a key growth engine, now operating 2,055 stores across...